Clinical trial
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
NCT01174121
Study timeline
Study start (actual)2010-08-26Date precision: day
Registry last updated2026-10-02
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Metastatic Colorectal Cancerunresolved
Metastatic Pancreatic Cancerunresolved
Metastatic Ovarian Cancerunresolved
Metastatic Breast Carcinomaunresolved
Interventions
FludarabineDRUG · verified · RxNorm: fludarabine
CyclophosphamideDRUG · verified · RxNorm: cyclophosphamide
AldesleukinDRUG · verified · RxNorm: aldesleukin
Young TILBIOLOGICAL
Sponsors & collaborators
National Cancer Institute (NCI)lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01174121 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.